Micrima Limited

At Micrima, we are reimagining breast cancer diagnosis. We aim to empower clinicians and women with information and tools to help diagnose breast cancer earlier. How do we do this? By providing a new breast tissue analysis method that quickly and safely produces breast density data, enabling personalised imaging and accurate breast cancer risk assessment for all women. Our medical device, Mi~Scan®, uses radio frequency and AI to analyse breast tissue properties, produce an industry-standard BI-RADS breast density classification, and other density insights. This density data is integrated with two leading breast cancer risk calculation models within our Mi~Score® software for accurate breast cancer risk calculation. Our ultimate goal is to improve outcomes and support proactive, informed decisions in women's healthcare and to ensure all women are aware of their breast cancer risk